Kliničke studije za Гојазност u državi Arizona
40 studija za Гојазност traži učesnike na lokacijama u državi Arizona.
Gradovi u državi Arizona
- Tucson20 студија
- Phoenix19 студија
- Scottsdale6 студија
- Chandler4 студија
- Gilbert4 студија
- Surprise3 студија
- Mesa3 студија
- Peoria3 студија
Zvanični tekst studije (na engleskom)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Arizona Clinical Trials, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351045A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Arizona Clinical Trials, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Arizona Clinical Trials, Chandler
- Epic Medical Research - Sun City, Sun City
- Clinical Research Institute of Arizona LLC, Sun City West
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- AMR Clinical, Tempe
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Tucson Clinical Research Institute, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Medical Dermatology Specialists, Phoenix
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06857942Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- University of Arizona, Tucson
Тражи се учесникФаза 3
Узраст од 6 до 11 · Оба пола · Ажурирано 4. 11. 2026. · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Tucson Clinical Research Institute, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- RIO Clinical Trials - Phoenix, Phoenix
- Headlands Research - Scottsdale, Scottsdale
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Care Access - 801 South Power Road, Mesa, Mesa
- Elite Pain and Spine Institute - South Crimson Road, Mesa
- Elite Clinical Studies, LLC, Phoenix
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
- Noble Clinical Research, LLC, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07915609A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Arizona, Tucson
Тражи се учесникФаза 3
Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Helios Clinical Research - Phoenix, Phoenix
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802Early Tracking of Childhood Health Determinants (ETCHED) Study
- NIDDK, Phoenix, Phoenix
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
1 Day – 99 Years · Оба пола · Ажурирано 2. 11. 2026. · NCT03481829Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
- Arizona Research Center, Phoenix
Тражи се учесникФаза 1
Узраст од 18 до 70 · Оба пола · Ажурирано 2. 11. 2026. · NCT07908316A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Mesa
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Medical Advancement Centers of Arizona, Phoenix
- Pima Heart and Vascular Clinical Research, Tucson
- Yuma Clinical Trials, Yuma
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Mesa
- Research Site, Phoenix
- Research Site, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Headlands Research - Scottsdale /ID# 282571, Scottsdale
- Arizona Clinical Trials /ID# 282372, Tucson
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07752979Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
- Exponent Phoenix, Phoenix
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07776678Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- DM Clinical Research, Sun City
- AMR Clinical, Tempe
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07837973A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Chandler
- ACCOMPLISH-2 Research Site, Phoenix
- ACCOMPLISH-2 Research Site, Sun City West
- и још 1
Тражи се учесникФаза 3Здраве особе су добродошле
Узраст од 18 до 79 · Оба пола · Ажурирано 20. 10. 2026. · NCT07654374The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Banner Health, Gilbert
- M3 Wake Research, Tucson
Тражи се учесник
Узраст од 22 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04101669A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
- Headlands Research - Scottsdale, Scottsdale
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07589608A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
- Headlands Research - Scottsdale, Scottsdale
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT06143956AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Dignity Health, Mercy Gilbert, Gilbert
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07571109Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Gilbert Center for Family Medicine, Gilbert
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Headlands Research - Scottsdale, Scottsdale
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07321886Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NIDDK, Phoenix, Phoenix
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 99 · Оба пола · Ажурирано 21. 9. 2026. · NCT06223555A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Peoria
- AURORA-2 Clinical Site, Phoenix
- AURORA-2 Clinical Site, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Phoenix
- AURORA-1 Clinical Site, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743463The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
- NIDDK, Phoenix, Phoenix
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 60 · Оба пола · Ажурирано 28. 8. 2026. · NCT05545306A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Mercy Gilbert Medical Center, Gilbert
- Sun City Clinical Research, Glendale
- Honor Health, Phoenix
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07567001Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Phoenix
- ACCOMPLISH-1 Research Site, Sun City West
- ACCOMPLISH-1 Research Site, Tucson
Тражи се учесникФаза 3
Узраст од 18 до 79 · Оба пола · Ажурирано 10. 8. 2026. · NCT07654361Fibrosis Lessens After Metabolic Surgery
- Banner Health Center, Phoenix
Тражи се учесникФаза 4Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 31. 7. 2026. · NCT06374875A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Arizona Research Center, Inc., Phoenix
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 7. 2026. · NCT07481630Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
- Mayo Clinic in Arizona, Scottsdale
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 30 до 70 · Оба пола · Ажурирано 28. 1. 2026. · NCT04232566Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- The University of Arizona College of Medicine- Phoenix, Phoenix
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 14. 11. 2025. · NCT06499857A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- PRANDIAL Lab, Flagstaff
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 14. 11. 2024. · NCT04755062Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.